Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

NCT01296815 is registered in ClinicalTrials.gov with Centro de Investigación en. Enfermedades Infecciosas, Mexico as lead sponsor.

NCT NCT01296815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01296815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Lead sponsor
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2013
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kaposi´s sarcoma